Randomised trial of monoclonal antibody for adjuvant therapy of resected Dukes' C colorectal carcinoma

[1]  J. Izbicki,et al.  Differential expression of proliferation-associated molecules in individual micrometastatic carcinoma cells. , 1993, Journal of the National Cancer Institute.

[2]  S. Braun,et al.  Micrometastatic tumour cells in bone marrow in colorectal cancer , 1993, The Lancet.

[3]  G. Riethmüller,et al.  Monoclonal antibodies in the detection and therapy of micrometastatic epithelial cancers. , 1992 .

[4]  G. Schlimok,et al.  Prognostic significance of micrometastatic tumour cells in bone marrow of colorectal cancer patients , 1992, The Lancet.

[5]  W. Willett,et al.  Breast cancer (1) , 1992, The New England journal of medicine.

[6]  J. Fagerberg,et al.  The therapeutic use of monoclonal antibodies in colorectal carcinoma. , 1991, Seminars in oncology.

[7]  D. Scheinberg.  Current applications of monoclonal antibodies for the therapy of hematopoietic cancers. , 1991, Current opinion in immunology.

[8]  C. Kosmas,et al.  Patients receiving murine monoclonal antibody therapy for malignancy develop T cells that proliferate in vitro in response to these antibodies as antigens. , 1991, British Journal of Cancer.

[9]  L. Lindholm,et al.  Tumour‐growth suppression in nude mice by a murine monoclonal antibody: Factors hampering successful therapy , 1991, International Journal of Cancer.

[10]  W. Meyers,et al.  Effective surgical adjuvant therapy for high-risk rectal carcinoma. , 1991, The New England journal of medicine.

[11]  S. Szala,et al.  Molecular cloning of cDNA for the carcinoma-associated antigen GA733-2. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[12]  L. Ries,et al.  Leukemia following chemotherapy for breast cancer. , 1990, Cancer research.

[13]  K. Isselbacher,et al.  Epithelial glycoprotein is a member of a family of epithelial cell surface antigens homologous to nidogen, a matrix adhesion protein. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[14]  T R Fleming,et al.  Levamisole and fluorouracil for adjuvant therapy of resected colon carcinoma. , 1990, The New England journal of medicine.

[15]  J. Ghrayeb,et al.  Mouse/human chimeric monoclonal antibody in man: kinetics and immune response. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[16]  M S Perez,et al.  Isolation and characterization of a cDNA encoding the KS1/4 epithelial carcinoma marker. , 1989, Journal of immunology.

[17]  J. R. Sportsman,et al.  Molecular cloning and characterization of a human adenocarcinoma/epithelial cell surface antigen complementary DNA. , 1989, Cancer research.

[18]  J. Lehmann,et al.  Immunological Analysis of Micrometastases and the Metastatic Phenotype of Human Tumors , 1989 .

[19]  M. Klinger,et al.  Enhanced cytotoxicity against colon carcinoma by combinations of noncompeting monoclonal antibodies to the 17-1A antigen. , 1988, Cancer research.

[20]  H. Rockette,et al.  Postoperative adjuvant chemotherapy or radiation therapy for rectal cancer: results from NSABP protocol R-01. , 1988, Journal of the National Cancer Institute.

[21]  B. Dörken,et al.  Antibodies as antigens. The use of mouse monoclonal antibodies to focus human T cells against selected targets , 1988, The Journal of experimental medicine.

[22]  G. Riethmüller,et al.  The epithelial cell surface antigen 17–1A, a target for antibody‐mediated tumor therapy: Its biochemical nature, tissue distribution and recognition by different monoclonal antibodies , 1986, International journal of cancer.

[23]  M. Herlyn,et al.  Release of monoclonal antibody-defined antigens by human colorectal carcinoma and melanoma cells. , 1981, Cancer Research.

[24]  M. Herlyn,et al.  Inhibition of growth of colorectal carcinoma in nude mice by monoclonal antibody. , 1980, Cancer research.

[25]  M. Herlyn,et al.  Colorectal carcinoma antigens detected by hybridoma antibodies , 1979, Somatic cell genetics.

[26]  M. Zelen.  A new design for randomized clinical trials. , 1979, The New England journal of medicine.

[27]  M. Herlyn,et al.  Colorectal carcinoma-specific antigen: detection by means of monoclonal antibodies. , 1979, Proceedings of the National Academy of Sciences of the United States of America.

[28]  C. Milstein,et al.  Continuous cultures of fused cells secreting antibody of predefined specificity , 1975, Nature.

[29]  M Zelen,et al.  The randomization and stratification of patients to clinical trials. , 1974, Journal of chronic diseases.